TMPRSS2 and infection: Consistent with the finding that enzalutamide could not reduce TMPRSS2 expression in H2126 cells, enzalutamide did not inhibit infection of either H2126 cells or AR-negative Calu-3 cells by SARS-CoV-2-S (Supplementary Fig. 5i, j).